National Planning Corporation’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

National Planning Corporation’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-50	Closed	-$848	–	2686
2014 Q4	$848	Buy	+50	New	+$703	﹤0.01%	2712

National Planning Corporation's AVNR Position: Q1 2015 in Review

National Planning Corporation sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 50 shares — an estimated $848 sold.

National Planning Corporation first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $848 in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

National Planning Corporation reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
National Planning Corporation sold 50 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $848.
National Planning Corporation first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
National Planning Corporation's AVANIR PHARMACEUTICALS, INC CL A position peaked at $848 in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on National Planning Corporation's 13F filing for Q1 2015, filed 12 May 2015.